辅助生殖技术与单胎妊娠死产风险的系统综述与荟萃分析
结果显示,与自然受孕相比,IVF或IVF-ICSI单胎妊娠的死产风险显著增加,合并OR为1.82(95%CI 1.37-2.42),未见发表偏倚证据。
要点
- IVF/IVF-ICSI单胎妊娠死产风险较自然受孕显著升高,合并OR 1.82(95%CI 1.37-2.42)。
- 荟萃分析未发现发表偏倚证据。
核心结论
- 与自然受孕相比,IVF和IVF-ICSI治疗 increase 单胎妊娠的死产风险。
研究设计与样本
- 系统文献检索与检索链法,检索PubMed、Embase和Scopus数据库,共纳入19项研究。
主要发现
- 荟萃分析显示IVF/IVF-ICSI单胎妊娠死产风险较自然受孕显著增加,OR为1.82(95%CI 1.37-2.42)。
- 未发现发表偏倚证据。
关键数值与推荐
- 主要结局指标为死产的调整OR或匹配研究中IVF/IVF-ICSI单胎与自然受孕单胎的死产患病率。
临床怎么用
- 对IVF/IVF-ICSI单胎妊娠应加强孕期监测,关注死产风险。
局限性
- 纳入研究质量参差不齐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the risk of stillbirth from in vitro types of assisted reproductive technologies compared with spontaneous conception (SC), limited to singleton births. DESIGN: Systematic literature search and search chaining on online databases: PubMed, Embase, and Scopus. SETTING: Not applicable. PATIENT(S): Singleton pregnancies from in vitro fertilization (IVF) or fertilization by IVF and intracytoplasmic sperm injection (IVF-ICSI). INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Adjusted odds ratio for stillbirth or prevalence of stillbirth in case-control groups of IVF/IVF-ICSI singletons and SCs, respectively, in matched studies. RESULT(S): A total of 19 studies were included, and study quality was mixed. Ten studies qualified for inclusion to the meta-analysis, which revealed a significantly increased risk of stillbirth in IVF/IVF-ICSI compared with that in SC (odds ratio [95% confidence interval]: 1.82 [1.37-2.42]), and there was no evidence of publication bias. CONCLUSION(S): In vitro fertilization and IVF-ICSI treatment increases the risk of stillbirth compared with natural conception. CLINICAL TRIAL REGISTRATION NUMBER: PROSPERO 216768.
引用
- Sarmon KG, Eliasen T, Knudsen UB, et al. Assisted reproductive technologies and the risk of stillbirth in singleton pregnancies: a systematic review and meta-analysis. Fertil Steril. 2021. PMID: 34023069. doi:10.1016/j.fertnstert.2021.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。